Added to YB: 2024-09-19
Pitch date: 2024-06-30
IQV [bullish]
IQVIA Holdings Inc.
+4.52%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
IQVIA Holdings Inc. provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific.
Market Cap
$38.5B
Pitch Price
$212.64
Price Target
N/A
Dividend
N/A
EV/EBITDA
16.87
P/E
30.92
EV/Sales
3.26
Sector
Life Sciences Tools and Services
Category
growth
Show full summary:
Harris Associates U.S. Concentrated Strategy Portfolio Holding: IQVIA Holdings Inc.
IQV: Q1 results in-line, stock fell. Clinical trials outlook positive, tech/analytics segment improving H2 2023 & 2024. Above-average long-term growth expected despite trading at discount to peers in life sciences and data/info services sectors.
Read full article (1 min)